Free Trial

Enhabit (EHAB) Competitors

Enhabit logo
$10.26 -0.17 (-1.58%)
Closing price 05/22/2025 03:59 PM Eastern
Extended Trading
$10.26 -0.01 (-0.05%)
As of 05/22/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

EHAB vs. ADUS, PGNY, PACS, WGS, NHC, TDOC, GRAL, AHCO, AGL, and AVAH

Should you be buying Enhabit stock or one of its competitors? The main competitors of Enhabit include Addus HomeCare (ADUS), Progyny (PGNY), PACS Group (PACS), GeneDx (WGS), National HealthCare (NHC), Teladoc Health (TDOC), Grail (GRAL), AdaptHealth (AHCO), agilon health (AGL), and Aveanna Healthcare (AVAH). These companies are all part of the "healthcare" industry.

Enhabit vs.

Addus HomeCare (NASDAQ:ADUS) and Enhabit (NYSE:EHAB) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, earnings, risk, valuation, institutional ownership, media sentiment, dividends, analyst recommendations and community ranking.

Addus HomeCare received 327 more outperform votes than Enhabit when rated by MarketBeat users. Likewise, 69.02% of users gave Addus HomeCare an outperform vote while only 17.24% of users gave Enhabit an outperform vote.

CompanyUnderperformOutperform
Addus HomeCareOutperform Votes
332
69.02%
Underperform Votes
149
30.98%
EnhabitOutperform Votes
5
17.24%
Underperform Votes
24
82.76%

Addus HomeCare currently has a consensus price target of $142.57, suggesting a potential upside of 27.83%. Enhabit has a consensus price target of $8.50, suggesting a potential downside of 17.19%. Given Addus HomeCare's stronger consensus rating and higher probable upside, research analysts clearly believe Addus HomeCare is more favorable than Enhabit.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Addus HomeCare
0 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
2 Strong Buy rating(s)
3.25
Enhabit
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

95.3% of Addus HomeCare shares are owned by institutional investors. 4.6% of Addus HomeCare shares are owned by insiders. Comparatively, 1.9% of Enhabit shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, Addus HomeCare had 4 more articles in the media than Enhabit. MarketBeat recorded 13 mentions for Addus HomeCare and 9 mentions for Enhabit. Enhabit's average media sentiment score of 1.39 beat Addus HomeCare's score of 0.85 indicating that Enhabit is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Addus HomeCare
8 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Enhabit
8 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Addus HomeCare has higher revenue and earnings than Enhabit. Enhabit is trading at a lower price-to-earnings ratio than Addus HomeCare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Addus HomeCare$1.21B1.69$62.52M$4.4325.18
Enhabit$1.03B0.50-$80.50M-$2.77-3.71

Addus HomeCare has a beta of 0.85, suggesting that its share price is 15% less volatile than the S&P 500. Comparatively, Enhabit has a beta of 1.61, suggesting that its share price is 61% more volatile than the S&P 500.

Addus HomeCare has a net margin of 6.50% compared to Enhabit's net margin of -11.24%. Addus HomeCare's return on equity of 9.62% beat Enhabit's return on equity.

Company Net Margins Return on Equity Return on Assets
Addus HomeCare6.50% 9.62% 7.37%
Enhabit -11.24%1.67%0.80%

Summary

Addus HomeCare beats Enhabit on 17 of the 19 factors compared between the two stocks.

Get Enhabit News Delivered to You Automatically

Sign up to receive the latest news and ratings for EHAB and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EHAB vs. The Competition

MetricEnhabitHome health care services IndustryMedical SectorNYSE Exchange
Market Cap$519.79M$3.16B$5.33B$19.30B
Dividend YieldN/A0.34%5.21%3.83%
P/E Ratio-4.4229.4826.7934.53
Price / Sales0.501.13393.6934.84
Price / Cash3.2517.2938.2517.51
Price / Book0.743.596.774.69
Net Income-$80.50M-$57.02M$3.23B$1.02B
7 Day Performance-3.57%-3.66%0.42%-2.43%
1 Month Performance36.50%15.03%9.06%6.27%
1 Year Performance11.82%26.93%18.55%5.78%

Enhabit Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EHAB
Enhabit
2.0674 of 5 stars
$10.27
-1.6%
$8.50
-17.2%
+9.0%$519.79M$1.03B-4.4210,900Positive News
ADUS
Addus HomeCare
4.7852 of 5 stars
$110.55
-0.3%
$142.57
+29.0%
+1.1%$2.04B$1.21B25.3033,200
PGNY
Progyny
1.4925 of 5 stars
$22.00
+3.8%
$23.45
+6.6%
-21.9%$1.88B$1.17B37.93310Positive News
PACS
PACS Group
3.4057 of 5 stars
$11.12
+6.6%
$34.00
+205.8%
-64.6%$1.69B$3.56B0.0032,433Gap Up
WGS
GeneDx
3.9509 of 5 stars
$59.00
-0.2%
$86.57
+46.7%
+236.8%$1.66B$330.14M-30.101,200Positive News
NHC
National HealthCare
N/A$102.14
+1.6%
N/A+2.0%$1.58B$1.37B12.8012,400Positive News
TDOC
Teladoc Health
3.6632 of 5 stars
$7.36
+3.4%
$9.71
+32.0%
-42.0%$1.29B$2.55B-1.275,100Gap Up
GRAL
Grail
0.8006 of 5 stars
$35.99
+2.2%
$26.00
-27.8%
N/A$1.27B$125.60M0.001,360Positive News
Gap Up
AHCO
AdaptHealth
2.5578 of 5 stars
$9.11
+6.3%
$13.40
+47.1%
-8.0%$1.23B$3.25B-5.5210,900Positive News
AGL
agilon health
2.1339 of 5 stars
$2.97
+2.6%
$4.89
+65.0%
-63.1%$1.23B$5.99B-3.15650
AVAH
Aveanna Healthcare
0.5795 of 5 stars
$5.78
+7.0%
$5.13
-11.3%
+89.7%$1.13B$2.02B-17.0033,000Insider Trade
High Trading Volume

Related Companies and Tools


This page (NYSE:EHAB) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners